Recent Updates
Recently added Catalysts
INDV Neutral Sentiment Score: 60/100

Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st Indivior PLC (Nasdaq / LSE: INDV) today announced that it will report second quarter 2025 financial results on Thursday, July 31, 2025 at 7:00 a.m. U....

Key Takeaway: Indivior PLC has announced it will report its financial results for the second quarter of 2025 on July 31, 2025. Following the report, CEO Joe Ciaffoni and the leadership team will conduct a live webcast presentation to discuss the results. The event will be available for access through the company's website, with replay options following the presentation. Indivior focuses on tailored treatments for opioid use disorder and aims to enhance patient care worldwide.

Market Sentiment Analysis

POSITIVE FACTORS

  • Indivior to report second quarter 2025 financial results soon.
  • CEO Joe Ciaffoni will present the results via live webcast.
  • Company is dedicated to developing medicines for opioid use disorder.

Full Press Release Details

RICHMOND, Va. , July 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq / LSE: INDV) today announced that it will report second quarter 2025 financial results on Thursday, July 31, 2025 at 7:00 a.m. U.S. ET. Following the release of the financial results, Joe Ciaffoni , Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. ET.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins.
Participants may access the presentation telephonically by registering with the following link: https://register-conf.media-server.com/register/BIb74823c247374ec38580055874599386 ( Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com .
About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder ( OUD ). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond , VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior .
SOURCE Indivior PLC

21 %

Frequently Asked Questions

When will Indivior report its second quarter 2025 financial results?

Indivior will report its Q2 2025 financial results on July 31, 2025, at 7:00 a.m. ET.

How can I access the Indivior financial results presentation?

The presentation can be accessed via the Investors section of Indivior's website.

Who will host the presentation after the financial results are released?

Joe Ciaffoni, the CEO of Indivior, will host the presentation with other leadership members.

Is there a way to attend the presentation by phone?

Yes, participants can register online to attend the presentation telephonically.

What is Indivior's main focus as a pharmaceutical company?

Indivior focuses on developing medicines to treat opioid use disorder (OUD).

Last updated: Jul 17, 2025